B50.8 Other severe and complicated Plasmodium falciparum malaria

Name of the Condition

• Other severe and complicated Plasmodium falciparum malaria

Summary

Other severe and complicated Plasmodium falciparum malaria represents a category of severe malaria manifestations caused by the Plasmodium falciparum parasite, excluding cerebral complications. It is transmitted through the bite of infected Anopheles mosquitoes and is endemic in tropical and subtropical regions. The condition progresses rapidly and can lead to life-threatening complications if not promptly treated. Clinical manifestations include severe systemic signs and organ dysfunction beyond neurological involvement.

Causes

The disease is caused by the Plasmodium falciparum parasite, which is transmitted to humans via the bite of infected female Anopheles mosquitoes. Once in the bloodstream, the parasite invades red blood cells, multiplying and causing symptoms. The parasite's life cycle involves both human and mosquito hosts, with transmission occurring when an infected mosquito bites a susceptible individual. Severe and complicated forms arise due to high parasite burden, sequestration of infected red blood cells in microvasculature, and systemic inflammatory responses.

Risk Factors

• Residence in or travel to malaria-endemic areas, particularly in sub-Saharan Africa, Southeast Asia, and the Amazon region.
• Lack of immunity, including travelers from non-endemic regions or young children in endemic areas.
• Incomplete or absent chemoprophylaxis during travel to high-risk areas.
• Pregnancy, which increases susceptibility to severe disease.
• HIV infection or other immunocompromising conditions.
• Delayed or inadequate treatment of uncomplicated malaria.

Symptoms

• High fever, often with chills and sweats.
• Severe anemia due to hemolysis of infected red blood cells.
• Jaundice from hemolysis and liver dysfunction.
• Acute kidney injury or renal failure.
• Respiratory distress or acute lung injury.
• Hypoglycemia, especially in pregnant women or children.
• Metabolic acidosis.
• Prostration or altered consciousness (excluding cerebral malaria criteria).

Diagnosis

Diagnosis is based on clinical presentation, travel history, and laboratory confirmation. Microscopic examination of blood smears remains the gold standard for detecting Plasmodium falciparum parasites. Rapid diagnostic tests (RDTs) for malaria antigens provide quick results but may miss low parasitemia. Additional tests include complete blood count (CBC) to assess anemia and thrombocytopenia, blood chemistry for organ function, and blood glucose monitoring. In severe cases, imaging or lumbar puncture may be performed to rule out other complications.

Treatment Options

Treatment requires prompt initiation of antimalarial therapy, typically with intravenous or intramuscular artesunate as first-line. Supportive care includes managing complications such as fluid resuscitation, blood transfusion for severe anemia, dialysis for renal failure, and glucose supplementation. Adjunctive therapies may address seizures, hypoglycemia, or respiratory distress. Once stable, patients transition to oral antimalarials to complete the treatment course.

Prognosis and Follow-Up

Prognosis depends on the severity of complications, timeliness of treatment, and underlying health status. Early intervention improves outcomes, but severe cases carry a high risk of mortality. Follow-up includes monitoring for treatment response, resolution of complications, and prevention of relapse. Patients should be evaluated for residual organ dysfunction and provided with education on malaria prevention for future travel.

Complications

• Severe anemia requiring transfusion.
• Acute kidney injury or renal failure.
• Respiratory distress or acute respiratory distress syndrome (ARDS).
• Hypoglycemia leading to coma or seizures.
• Metabolic acidosis.
• Multi-organ failure.
• Death in untreated or delayed cases.

Lifestyle & Prevention

• Use insect repellent and wear protective clothing in endemic areas.
• Sleep under insecticide-treated bed nets.
• Take chemoprophylaxis as prescribed for travel to high-risk regions.
• Seek prompt medical care for fever during or after travel to malaria-endemic areas.
• Avoid self-treatment with over-the-counter medications without diagnostic confirmation.

When to Seek Professional Help

Seek immediate medical attention if you experience fever, chills, or flu-like symptoms after traveling to a malaria-endemic region. Urgent care is required for signs of severe disease, including altered consciousness, difficulty breathing, jaundice, or inability to stand. Do not delay treatment, as malaria can progress rapidly.

Tips for Medical Coders

Code B50.8 is assigned for other severe and complicated Plasmodium falciparum malaria, excluding cerebral complications. Documentation should specify the severe manifestations (e.g., renal failure, respiratory distress) and confirm Plasmodium falciparum as the causative agent. Ensure differentiation from uncomplicated malaria or other severe malaria subtypes (e.g., cerebral malaria) to support accurate coding.